(Q38333986)

2 September 2017

Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential (English)

1 reference

2 September 2017

9

Walter Jonat

0 references

Jalid Sehouli

11

object named as

Jalid Sehouli

0 references

Ivo Meinhold-Heerlein

1

object named as

Ivo Meinhold-Heerlein

0 references

Norbert Arnold

16

object named as

Norbert Arnold

1 reference

2 September 2017

3

Felix Hilpert

1 reference

2 September 2017

Dirk Bauerschlag

2

1 reference

2 September 2017

Petre Dimitrov

4

1 reference

2 September 2017

Lisa M Sapinoso

5

1 reference

2 September 2017

Marzenna Orlowska-Volk

6

1 reference

2 September 2017

Thomas Bauknecht

7

1 reference

2 September 2017

Tjoung-Won Park

8

1 reference

2 September 2017

Anja Jacobsen

10

1 reference

2 September 2017

Jutta Luttges

12

1 reference

2 September 2017

Maryla Krajewski

13

1 reference

2 September 2017

Stan Krajewski

14

1 reference

2 September 2017

John C Reed

15

1 reference

2 September 2017

Garret M Hampton

17

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

2 September 2017

1 reference

2 September 2017

24

1 reference

2 September 2017

1053-1065

1 reference

2 September 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208298

2 September 2017

0 references

cites work

p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Cluster analysis and display of genome-wide expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Clinical management potential tumours of low malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Gadd34 functional domains involved in growth suppression and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Osteopontin as a potential diagnostic biomarker for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Prognostic significance of apoptosis regulators in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

JAK/STAT signaling by cytokine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Expression monitoring by hybridization to high-density oligonucleotide arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Inhibitors of JAKs/STATs and the kinases: a possible new cluster of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Gene expression in epithelial ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Expression and potential role of Fas-associated phosphatase-1 in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Prognostic factors for patients with advanced stage serous borderline tumours of the ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Emerging treatments for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Pathology of borderline (low malignant potential) ovarian tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Diverse tumorigenic pathways in ovarian serous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Expression of polo-like kinase in ovarian cancer is associated with histological grade and clinical stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Two-site ELISA for the quantitative determination of fatty acid synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

GADD34 induces p53 phosphorylation and p21/WAF1 transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

7 January 2021

Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

7 January 2021

Comparison of mutations of Ki-RAS and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

7 January 2021

Comparative genomic hybridization detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

7 January 2021

Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

7 January 2021

Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

7 January 2021

Fatty acid synthase (FAS) expression in human breast cancer cell culture supernatants and in breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208298

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1208298

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference